Pillstats
Tablet

Modafinil

Modafinil

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)30125
US makers3 labelers
Packages12
DEA / ScheduleCIV

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$15.25$30.49$45.74$60.98Nov 2025Mar 2026Jul 2026
$17.922
Latest avg · Jul 22, 2026
-66%
Since Nov 19, 2025
3
Active US suppliers
83%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.0K3.9K5.9K7.9K2025 Q12025 Q22025 Q32025 Q42026 Q1
4.9K
Rx · 2026 Q1
195K
Units dispensed
-26%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aurobindo Pharma Limitedunknown6SUPPLYING
Patheon Inc.unknown4SUPPLYING
Cephalon, LLCunknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.